🇺🇸 FDA
Patent

US 7208161

Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences

granted A61KA61K2039/5254A61K39/00

Quick answer

US patent 7208161 (Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
70
CPC classes
A61K, A61K2039/5254, A61K39/00